Table S9 from Phase I Study of Oncolytic Virus VV1 as Monotherapy or in Combination with Avelumab in Patients with Relapsed Refractory Solid Tumors
Year: 2026
Type: other
Abstract: Part 1 disease response and SPECT/CT positivity
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W7202214341
Cites:
Cited by:
Related to:
